Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differential HMGA expression and post-translational modifications in prostatic tumor cells.

Francesca Diana1, Julie Di Bernardo, Riccardo Sgarra

  • 1Dipartimento di Biochimica, Biofisica e Chimica delle Macromolecole, Università di Trieste, I-34127 Trieste, Italy.

International Journal of Oncology
|January 13, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prolyl-isomerase Pin1 drives platinum resistance by regulating Notch3 stability and function in ovarian cancer.

Journal of experimental & clinical cancer research : CR·2026
Same author

Unveiling the unfolded proteome: Evaluation and comparison of methods for the enrichment of intrinsically disordered proteins.

Protein science : a publication of the Protein Society·2026
Same author

Inhibition of HMGA2 Leads to Reduced Cell Proliferation and Increased Apoptosis in Human Embryonal Carcinoma Cell Lines.

Andrology·2026
Same author

p53 inactivation drives breast cancer metastasis to the brain through SCD1 upregulation and increased fatty acid metabolism.

Nature genetics·2025
Same author

Potential therapeutic targets and biomarkers in testicular germ cell tumor oncogenesis.

Expert opinion on therapeutic targets·2025
Same author

The Role of Anti-MDA5 Antibodies in Rapidly Progressive Interstitial Lung Disease: A Case Report and Literature Review.

Reviews on recent clinical trials·2025

High mobility group A (HMGA) proteins are crucial in cancer progression. This study found HMGA2 expression and specific HMGA1a methylation in metastatic prostate cancer cells, suggesting HMGA2 as a potential tumor marker.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • High mobility group A (HMGA) architectural nuclear factors regulate chromatin dynamics.
  • Overexpression of HMGA proteins is linked to neoplastic transformation and cancer progression.

Purpose of the Study:

  • To investigate the expression and post-translational modifications (PTMs) of HMGA proteins (HMGA1a, HMGA1b, HMGA2) in a rat prostate cancer model.
  • To evaluate the role of HMGA expression in prostate cancer cell growth and metastasis.

Main Methods:

  • Analysis of HMGA protein expression (HMGA1a, HMGA1b, HMGA2) in Dunning rat prostate cancer cell lines (G, AT-1, MAT-Ly-Lu).
  • Detection of HMGA1a post-translational modifications, specifically mono-methylation.
  • Ectopic expression of HMGA in HMGA-negative cells.

Related Experiment Videos

Main Results:

  • HMGA2, HMGA1a, and HMGA1b were expressed in anaplastic prostate cancer cell lines (AT-1, MAT-Ly-Lu).
  • Specific HMGA1a mono-methylation was observed exclusively in the highly metastatic MAT-Ly-Lu cell line.
  • Ectopic HMGA expression in HMGA-negative Dunning G cells did not significantly impact growth.

Conclusions:

  • HMGA2 is a potential biomarker for human prostate tumors.
  • Post-translational modifications of HMGA proteins may serve as additional tools for tumor progression staging.
  • HMGA expression is necessary but not sufficient for neoplastic transformation in all cellular contexts.